Description
Cartalax overview
Cartalax is a synthetic bioregulator tripeptide from the same short-peptide research tradition as Epithalon and Vesugen. It is studied in laboratory research on cartilage and connective-tissue cells.
Protides Health lists Cartalax 20mg in 20mg for laboratory research. The specification table below sets out the contents, molecular data and storage conditions, and the certificate of analysis is shown in the image gallery or linked in the product summary. You can compare related compounds in our bioregulator peptides collection.
Cartalax Peptide Specifications
| Property | Details |
|---|---|
| Product Contents | Cartalax 20mg Lyophilized Powder (99% purity) in 3mL vial. |
| Available Sizes | 20mg |
| Peptide Type | Synthetic bioregulatory tripeptide (3 amino acids) |
| Purity | 99% (HPLC-MS verified, third-party tested) |
| Molecular Formula | C12H19N3O8 |
| Molecular Weight | 333.29 g/mol |
| Sequence | Ala-Glu-Asp |
| CID | 87815447 |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at ≤6°C, sealed, away from heat, light, and moisture. |
| Solubility | Soluble in water |
Cartalax chemical structure
Two- and three-dimensional structures, identifiers and literature references are available from the U.S. National Library of Medicine’s PubChem database: PubChem CID 87815447.
Legal Disclaimer: Cartalax is sold by Protides Health, an independent retailer that is not affiliated with Protide Health, for laboratory research purposes only. This product is not approved by the FDA for human consumption, medical use, or veterinary use. By completing a purchase, you verify that you are a qualified researcher and must comply with applicable local, state, and federal regulations. Please review our Research Use Policy before purchasing.
Reviews
There are no reviews yet.